Cargando…
CCL20 is a potential therapeutic target associated with immune infiltration in breast cancer
OBJECTIVES: CCL20 is a chemotactic factor that is involved in immune cell recruitment and cancer progression. However, the role of CCL20 in the prognosis of breast cancer remains unclear. This study analyzed correlations between CCL20 expression and immune infiltration, clinicopathological parameter...
Autores principales: | Zhai, Hongyan, Zhang, Na, Mo, Dan, Qin, Tingting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423453/ https://www.ncbi.nlm.nih.gov/pubmed/37571985 http://dx.doi.org/10.1177/03000605231171762 |
Ejemplares similares
-
miR-147a suppresses the metastasis of non-small-cell lung cancer by targeting CCL5
por: Lu, Yan, et al.
Publicado: (2019) -
Oxaliplatin facilitates tumor-infiltration of T cells and natural-killer cells for enhanced tumor immunotherapy in lung cancer model
por: Xin, Min, et al.
Publicado: (2021) -
DNAJB11 predicts a poor prognosis and is associated with immune infiltration in thyroid carcinoma: a bioinformatics analysis
por: Sun, Rongxin, et al.
Publicado: (2021) -
FKBP5 associated CD8 T cell infiltration is a novel prognostic biomarker in luminal B breast cancer
por: Tong, Fei, et al.
Publicado: (2023) -
Saturated hydrogen alleviates CCl(4)-induced acute kidney injury via JAK2/STAT3/p65 signaling
por: Wu, Song, et al.
Publicado: (2020)